Cognition Therapeutics (CGTX) stock

Worth $63.7MShares as of Nov 2

$0.67

-2.95%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score CGTX. It is priced too low for a fair Quality Score.

Healthcare · Biotech

NextMid-2027“The registrational program is expected to begin in mid-2027.”Trial start · SEC filing · Jun 24

Follow CGTX's trial news. Pro members can get an alert when Cognition Therapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when CGTX files news on its trialSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

What's next for CGTX, and how long its cash lasts

Next step the company has named

Mid-2027“The registrational program is expected to begin in mid-2027.”Trial start · SEC filing · Jun 24

What it means: when a trial begins, or reaches the stage the company named.

A trial underway: Safety and Efficacy of CT1812 in Early Alzheimer's DiseasePhase 2 · Active · 540 people · main data estimated May 31, 2027 · NCT05531656

For Pro members: 41 filings.

Cash runway

The company says its cash lasts Into Q2 2027 (8-K, Jun 4).

That is the company's estimate. Our arithmetic on its latest balance sheet reads differently, so we show its words, not ours.

For Pro members: the cash on hand, the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (S-3, filed Dec 18, 2025)
At-the-market share sales program (S-3, filed Dec 18, 2025)

For Pro members: 3 raises and their amounts, and the share count against a year ago.

Insiders

CFO John Brendan Doyle bought 10,000 shares on Apr 16. 2 more insider trades this year.

From Form 4: open-market buys and sales only.

Get an alert when Lisa Ricciardi buys or sells

For Pro members: every trade, and Lisa Ricciardi’s 14 filings and quotes.

Get an alert when CGTX files news on its trialA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

CGTX's latest filings

Quarterly report10-Q, filed Nov 5
Cognition Therapeutics Reports Financial Results for the Third Quarter 2026 and Provides Business Update8-K, filed Nov 5
5 insider filingsForm 4, filed Jun 22

20 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why CGTX isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. CGTX trades at $0.67. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.